Rapamycin inhibits release of tumor necrosis factor-α from human vascular smooth muscle cells

American Surgeon

Volumn 70, Issue 5, 2004, Pages 384-387

  Adkins, Jonathan R ^a,c   Castresana, Manuel R ^b   Wang, Zhongbiao ^a   Newman, Walter H ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c HB 140 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BIOMATERIAL; CYCLIC AMP; IMMUNOSUPPRESSIVE AGENT; ISOPRENALINE; LIPOPOLYSACCHARIDE; RAPAMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ANALYSIS OF VARIANCE; ARTICLE; CELL CULTURE; CELL DIVISION; CELL MOTION; CORONARY ARTERY DISEASE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; EPIDEMIOLOGY; GRAFT OCCLUSION; HUMAN; IMMUNOLOGY; INFLAMMATION; INTIMA; PHYSIOLOGY; SAPHENOUS VEIN; STENT; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; CAUSALITY; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; CORONARY DISEASE; CYCLIC AMP; DRUG EVALUATION, PRECLINICAL; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; ISOPROTERENOL; LIPOPOLYSACCHARIDES; MUSCLE, SMOOTH, VASCULAR; SAPHENOUS VEIN; SIROLIMUS; STENTS; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA;

EID: 2542612167     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Babapulle MN, Eisenberg MJ. Coated stints for the prevention of restenosis: Part 1. Circulation 2002;106:2743-2840
2. Babapulle MN, Eisenberg MJ. Coated stints for the prevention of restenosis: Part 2. Circulation 2002;106:2859-2866 (Pubitemid 35396988)
3. Morice M-C, Serruys PW, Sousa JE, et al. A randomized comparison of a Sirolimus-eluting stint with a standard stint for coronary revascularization. N Engl J Med 2002;346:1773-1780
4. Marx SO, Jayaraman LOG, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 1995;76:412-417
5. Poon M, Marx SO, Gallo R, et al. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996;98:2277-2283 (Pubitemid 26394201)
6. Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996;127:263-271 (Pubitemid 27045840)
7. Tanaka H, Sukova G, Schwartz D, Libby P. Proliferating arterial smooth muscle cells after balloon injury express TNF-α but not interleukin-1 or basic fibroblast growth factor. Arterioscler Thromb Vasc Biol 1996;16:12-18. (Pubitemid 26026926)
8. Newman WH, Castresana MR, Webb JG, Wang Z. Cyclic AMP inhibits production of interleukin-6 and migration in human vascular smooth muscle cells. J Surg Res 2003;57:57-61. (Pubitemid 36263424)
9. Rechtenwald JE, Moldawer LL, Huber TS, et al. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 2000;102:1697-1702
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein dye binding. Anal Biochem 1976;72:248-254
11. Flick DA, Gifford GE. Comparison of in vitro cell cytotoxicity assay for tumor necrosis factor. J Immunol Methods 1984;68:167-175
12. Detmer K, Wang Z, Warejcka DJ, et al. Endotoxin stimulated cytokine production in rat vascular smooth muscle cells. Am J Physiol (Heart Circ Physiol) 2001;281:H661-H668. (Pubitemid 32756091)
13. Suzuki T, Kopia G, Hayashi S, et al. Stent-based sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001;104:1188-1193 (Pubitemid 32830406)
14. Newman WH, Castresana MR, Webb JG, et al. Isoproterenol inhibits transcription of cardiac cytokine genes induced by reactive oxygen intermediates. Anesthesiology 2002;96:947-954